Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

The Washing Machine as a Reservoir for Transmission of Extended-Spectrum-Beta-Lactamase (CTX-M-15)-Producing Klebsiella oxytoca ST201 to Newborns.

Schmithausen RM, Sib E, Exner M, Hack S, Rösing C, Ciorba P, Bierbaum G, Savin M, Bloomfield SF, Kaase M, Jacobshagen A, Gemein S, Gebel J, Engelhart S, Exner D.

Appl Environ Microbiol. 2019 Oct 30;85(22). pii: e01435-19. doi: 10.1128/AEM.01435-19. Print 2019 Nov 15.

2.

TA*p63 and GTAp63 achieve tighter transcriptional regulation in quality control by converting an inhibitory element into an additional transactivation domain.

Pitzius S, Osterburg C, Gebel J, Tascher G, Schäfer B, Zhou H, Münch C, Dötsch V.

Cell Death Dis. 2019 Sep 17;10(10):686. doi: 10.1038/s41419-019-1936-z.

3.

Interlaboratory reproducibility of a test method following 4-field test methodology to evaluate the susceptibility of Clostridium difficile spores.

Gemein S, Gebel J, Christiansen B, Martiny H, Vossebein L, Brill FHH, Decius M, Eggers M, Koburger-Janssen T, Meckel M, Werner S, Hunsinger B, Selhorst T, Kampf G, Exner M.

J Hosp Infect. 2019 Sep;103(1):78-84. doi: 10.1016/j.jhin.2019.04.011. Epub 2019 Jun 12.

4.

Towards complete polypeptide backbone NH assignment via combinatorial labeling.

Löhr F, Gebel J, Henrich E, Hein C, Dötsch V.

J Magn Reson. 2019 May;302:50-63. doi: 10.1016/j.jmr.2019.03.010. Epub 2019 Mar 29.

PMID:
30959416
5.

Deletions and loss-of-function variants in TP63 associated with orofacial clefting.

Khandelwal KD, van den Boogaard MH, Mehrem SL, Gebel J, Fagerberg C, van Beusekom E, van Binsbergen E, Topaloglu O, Steehouwer M, Gilissen C, Ishorst N, van Rooij IALM, Roeleveld N, Christensen K, Schoenaers J, Bergé S, Murray JC, Hens G, Devriendt K, Ludwig KU, Mangold E, Hoischen A, Zhou H, Dötsch V, Carels CEL, van Bokhoven H.

Eur J Hum Genet. 2019 Jul;27(7):1101-1112. doi: 10.1038/s41431-019-0370-0. Epub 2019 Mar 8.

PMID:
30850703
6.

Practical considerations for infection prevention of near-patient surfaces: validation of an alternative polyvinyl chloride carrier in the 4-field test EN 16615:2015.

Gemein S, Gebel J, Roques C, Steinhauer K; CEN/TC 216, WG 1.

J Hosp Infect. 2019 Sep;103(1):e118-e119. doi: 10.1016/j.jhin.2019.02.018. Epub 2019 Mar 2. No abstract available.

PMID:
30831186
7.

Isopropanol at 60% and at 70% are effective against 'isopropanol-tolerant' Enterococcus faecium.

Gebel J, Gemein S, Kampf G, Pidot SJ, Buetti N, Exner M.

J Hosp Infect. 2019 Sep;103(1):e88-e91. doi: 10.1016/j.jhin.2019.01.024. Epub 2019 Feb 1.

8.

Why volume matters - implications of applied volume of alcohol-based disinfectants for infection prevention.

Steinhauer K, Rödger HJ, Teckemeyer K, Christiansen B, Gebel J, Martiny H, Meyer B, Ostermeyer C, Vossebein L.

J Hosp Infect. 2019 Apr;101(4):423-425. doi: 10.1016/j.jhin.2018.09.015. Epub 2018 Sep 28. No abstract available.

PMID:
30273640
9.

Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.

Krauskopf K, Gebel J, Kazemi S, Tuppi M, Löhr F, Schäfer B, Koch J, Güntert P, Dötsch V, Kehrloesser S.

Structure. 2018 Aug 7;26(8):1091-1100.e4. doi: 10.1016/j.str.2018.05.013. Epub 2018 Jun 28.

10.

Response to J-Y. Maillard: Are amine-only-containing products sporicidal?

Gemein S, Meyer B, Gebel J, Roques C, Steinhauer K; CEN TC 216, WG1.

J Hosp Infect. 2018 Nov;100(3):e68-e69. doi: 10.1016/j.jhin.2018.04.021. Epub 2018 May 2. No abstract available.

PMID:
29729301
11.

Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism.

Nemajerova A, Amelio I, Gebel J, Dötsch V, Melino G, Moll UM.

Cell Death Differ. 2018 Jan;25(1):144-153. doi: 10.1038/cdd.2017.178. Epub 2017 Oct 27. Review.

12.

Control mechanisms in germ cells mediated by p53 family proteins.

Gebel J, Tuppi M, Krauskopf K, Coutandin D, Pitzius S, Kehrloesser S, Osterburg C, Dötsch V.

J Cell Sci. 2017 Aug 9. pii: jcs.204859. doi: 10.1242/jcs.204859. [Epub ahead of print] Review.

PMID:
28794013
13.

Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?

Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, Heeg P, Ilschner C, Kramer A, Larson E, Merkens W, Mielke M, Oltmanns P, Ross B, Rotter M, Schmithausen RM, Sonntag HG, Trautmann M.

GMS Hyg Infect Control. 2017 Apr 10;12:Doc05. doi: 10.3205/dgkh000290. eCollection 2017.

14.

Nurses Are as Specific and Are Earlier in Calling In-Hospital Stroke Alerts Compared to Physicians.

George P, Wisco DR, Gebel J, Uchino K, Newey CR.

J Stroke Cerebrovasc Dis. 2017 May;26(5):917-921. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.003. Epub 2017 Mar 22.

PMID:
28342656
15.

Prüfung und Deklaration der Wirksamkeit von Desinfektionsmitteln gegen Viren zur Anwendung im human-medizinischen Bereich : Stellungnahme des Arbeitskreises Viruzidie beim Robert Koch-Institut.

Schwebke I, Eggers M, Gebel J, Geisel B, Glebe D, Rapp I, Steinmann J, Rabenau F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Mar;60(3):353-363. doi: 10.1007/s00103-016-2509-2. German. No abstract available.

16.

Variables That Best Differentiate In-Patient Acute Stroke from Stroke-Mimics with Acute Neurological Deficits.

Natteru P, Mohebbi MR, George P, Wisco D, Gebel J, Newey CR.

Stroke Res Treat. 2016;2016:4393127. doi: 10.1155/2016/4393127. Epub 2016 Dec 6.

17.

Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization.

Gebel J, Luh LM, Coutandin D, Osterburg C, Löhr F, Schäfer B, Frombach AS, Sumyk M, Buchner L, Krojer T, Salah E, Mathea S, Güntert P, Knapp S, Dötsch V.

Cell Death Differ. 2016 Dec;23(12):1930-1940. doi: 10.1038/cdd.2016.83. Epub 2016 Oct 7.

18.

Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level.

Coutandin D, Osterburg C, Srivastav RK, Sumyk M, Kehrloesser S, Gebel J, Tuppi M, Hannewald J, Schäfer B, Salah E, Mathea S, Müller-Kuller U, Doutch J, Grez M, Knapp S, Dötsch V.

Elife. 2016 Mar 14;5. pii: e13909. doi: 10.7554/eLife.13909.

19.

Portable UV light as an alternative for decontamination.

Petersson LP, Albrecht UV, Sedlacek L, Gemein S, Gebel J, Vonberg RP.

Am J Infect Control. 2014 Dec;42(12):1334-6. doi: 10.1016/j.ajic.2014.08.012. Epub 2014 Nov 25.

PMID:
25465267
20.

Capillary Index Score in the Interventional Management of Stroke trials I and II.

Al-Ali F, Tomsick TA, Connors JJ 3rd, Gebel JM, Elias JJ, Markarian GZ, Al-Ali Z, Broderick JP.

Stroke. 2014 Jul;45(7):1999-2003. doi: 10.1161/STROKEAHA.114.005304. Epub 2014 May 22.

21.

Addition of hyperacute MRI AIDS in patient selection, decreasing the use of endovascular stroke therapy.

Wisco D, Uchino K, Saqqur M, Gebel JM, Aoki J, Alam S, George P, Newey CR, Man S, Tateishi Y, McNeil J, Winfield M, Cheng-Ching E, Hui FK, Toth G, Bain M, Rasmussen PA, Masaryk T, Ruggieri P, Hussain MS.

Stroke. 2014 Feb;45(2):467-72. doi: 10.1161/STROKEAHA.113.003880. Epub 2014 Jan 9.

PMID:
24407952
22.

The role of surface disinfection in infection prevention.

Gebel J, Exner M, French G, Chartier Y, Christiansen B, Gemein S, Goroncy-Bermes P, Hartemann P, Heudorf U, Kramer A, Maillard JY, Oltmanns P, Rotter M, Sonntag HG.

GMS Hyg Infect Control. 2013 Apr 29;8(1):Doc10. doi: 10.3205/dgkh000210. eCollection 2013.

23.

Analysis of the oligomeric state and transactivation potential of TAp73α.

Luh LM, Kehrloesser S, Deutsch GB, Gebel J, Coutandin D, Schäfer B, Agostini M, Melino G, Dötsch V.

Cell Death Differ. 2013 Aug;20(8):1008-16. doi: 10.1038/cdd.2013.23. Epub 2013 Mar 29.

24.

Re: Spread and persistence of Clostridium difficile spores during and after cleaning with sporicidal disinfectants.

Meyer B, Exner M, Gebel J.

J Hosp Infect. 2012 Feb;80(2):185; author reply 186. doi: 10.1016/j.jhin.2011.10.016. Epub 2011 Dec 14. No abstract available.

PMID:
22172407
25.

Long-term effects of disinfectants on the community composition of drinking water biofilms.

Roeder RS, Lenz J, Tarne P, Gebel J, Exner M, Szewzyk U.

Int J Hyg Environ Health. 2010 Jun;213(3):183-9. doi: 10.1016/j.ijheh.2010.04.007. Epub 2010 May 21.

PMID:
20494617
26.

Verification of the efficiency of chemical disinfection and sanitation measures in in-building distribution systems.

Lenz J, Linke S, Gemein S, Exner M, Gebel J.

Int J Hyg Environ Health. 2010 Jun;213(3):198-203. doi: 10.1016/j.ijheh.2010.04.006. Epub 2010 May 15.

PMID:
20472500
27.

Detection of Helicobacter pylori in biofilms by real-time PCR.

Linke S, Lenz J, Gemein S, Exner M, Gebel J.

Int J Hyg Environ Health. 2010 Jun;213(3):176-82. doi: 10.1016/j.ijheh.2010.03.006. Epub 2010 Apr 27.

PMID:
20427237
28.

Heterogeneity of efficacy and safety of antiplatelet therapy in cardiovascular and cerebrovascular disease.

Gebel JM.

Am J Cardiovasc Drugs. 2010;10(2):115-24. doi: 10.2165/11319580-000000000-00000. Review.

PMID:
20334449
29.

[Hygiene tips for kids. Concept and examples of realisation].

Gebel J, Teichert-Barthel U, Hornbach-Beckers S, Vogt A, Kehr B, Littmann M, Kupfernagel F, Ilschner C, Simon A, Exner M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Nov;51(11):1304-13. doi: 10.1007/s00103-008-0697-0. German.

PMID:
19043759
30.

[Risk of infection in the home environment. Plea for a new risk assessment].

Exner M, Gebel J, Heudorf U, Fischnaller E, Engelhart S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Nov;51(11):1247-57. doi: 10.1007/s00103-008-0694-3. Review. German.

PMID:
19043752
31.

The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.

Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J Jr, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ; CLEAR Trial Investigators.

Stroke. 2008 Dec;39(12):3268-76. doi: 10.1161/STROKEAHA.108.517656. Epub 2008 Sep 4.

32.

The CAPRIE-like subgroups of CHARISMA: a CAPRIEciously biased analysis of an unCHARISMAtic truth.

Gebel JM Jr.

J Am Coll Cardiol. 2007 Oct 23;50(17):1704; author reply 1704-5. No abstract available.

33.

The effect of race and gender on patterns of rt-PA use within a population.

Kleindorfer D, Schneider A, Kissela BM, Woo D, Khoury J, Alwell K, Miller R, Gebel J, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Shukla R, Broderick JP.

J Stroke Cerebrovasc Dis. 2003 Sep-Oct;12(5):217-20.

PMID:
17903930
34.

Intra-arterial thrombolysis for acute ischemic stroke.

Jovin T, Gebel JM, Wechsler LR.

J Stroke Cerebrovasc Dis. 2002 May-Aug;11(3-4):148-61.

PMID:
17903871
35.

Carotid endarterectomy in the elderly.

Dandapani BK, Shah S, Gebel JM Jr, Grove MK, Sesto ME, Parks P.

J Stroke Cerebrovasc Dis. 1999 Jan-Feb;8(1):28-32.

PMID:
17895134
36.

[Water as a reservoir for nosocomial infections in health care facilities, prevention and control].

Exner M, Kramer A, Kistemann T, Gebel J, Engelhart S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Mar;50(3):302-11. German.

PMID:
17334890
37.

Pretreatment ipsilateral regional cortical blood flow influences vessel recanalization in intra-arterial thrombolysis for MCA occlusion.

Jovin TG, Gupta R, Horowitz MB, Grahovac SZ, Jungreis CA, Wechsler L, Gebel JM, Yonas H.

AJNR Am J Neuroradiol. 2007 Jan;28(1):164-7.

38.

Testing and listing disinfectants - instrument and product of quality assurance.

Gebel J.

GMS Krankenhhyg Interdiszip. 2007 Sep 13;2(1):Doc17.

39.

Quantitative perihematomal blood flow in spontaneous intracerebral hemorrhage predicts in-hospital functional outcome.

Tayal AH, Gupta R, Yonas H, Jovin T, Uchino K, Hammer M, Wechsler L, Gebel JM.

Stroke. 2007 Feb;38(2):319-24. Epub 2006 Dec 28.

PMID:
17194883
40.

Reduced pretreatment ipsilateral middle cerebral artery cerebral blood flow is predictive of symptomatic hemorrhage post-intra-arterial thrombolysis in patients with middle cerebral artery occlusion.

Gupta R, Yonas H, Gebel J, Goldstein S, Horowitz M, Grahovac SZ, Wechsler LR, Hammer MD, Uchino K, Jovin TG.

Stroke. 2006 Oct;37(10):2526-30. Epub 2006 Sep 7.

PMID:
16960093
41.

Differentiating hemodynamic compromise by the OEF response to acetazolamide in occlusive vascular disease.

Nemoto EM, Yonas H, Kuwabara H, Pindzola R, Sashin D, Chang Y, Jovin T, Gebel J, Hammer MD, Wechsler L.

Adv Exp Med Biol. 2005;566:135-41.

PMID:
16594145
42.

Process-independent quantitative assessment of residual biological contamination of medical devices reprocessed in washer-disinfectors.

Sigler K, Chládková K, Vacata V, Gebel J, Gásková D.

Folia Microbiol (Praha). 2005;50(3):239-46.

PMID:
16295663
44.

Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial.

Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, Decesare S, Jovin T, Zafonte R, Lebowitz J, Flickinger JC, Tong D, Marks MP, Jamieson C, Luu D, Bell-Stephens T, Teraoka J.

J Neurosurg. 2005 Jul;103(1):38-45.

PMID:
16121971
45.

High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer.

Jovin TG, Boosupalli V, Zivkovic SA, Wechsler LR, Gebel JM.

Neurology. 2005 Jun 14;64(11):1944-5.

PMID:
15955949
46.

Prevention and control of health care-associated waterborne infections in health care facilities.

Exner M, Kramer A, Lajoie L, Gebel J, Engelhart S, Hartemann P.

Am J Infect Control. 2005 Jun;33(5 Suppl 1):S26-40. Review.

PMID:
15940114
47.

Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study.

Kissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, Miller R, Ewing I, Moomaw CJ, Szaflarski JP, Gebel J, Shukla R, Broderick JP.

Diabetes Care. 2005 Feb;28(2):355-9.

PMID:
15677792
48.

Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes.

Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL.

Diabetes Care. 2005 Jan;28(1):10-4.

PMID:
15616226
49.

Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites.

Schneider AT, Kissela B, Woo D, Kleindorfer D, Alwell K, Miller R, Szaflarski J, Gebel J, Khoury J, Shukla R, Moomaw C, Pancioli A, Jauch E, Broderick J.

Stroke. 2004 Jul;35(7):1552-6. Epub 2004 May 20.

PMID:
15155974
50.

Effect of untreated hypertension on hemorrhagic stroke.

Woo D, Haverbusch M, Sekar P, Kissela B, Khoury J, Schneider A, Kleindorfer D, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Sauerbeck L, Gebel J, Broderick J.

Stroke. 2004 Jul;35(7):1703-8. Epub 2004 May 20.

PMID:
15155969

Supplemental Content

Support Center